Papp K, Lebwohl M, Gottlieb A, Sebastian M, Langley R, Okubo Y, Wang M, Cioffi C, Staelens F, Reich K. Bimekizumab for the Treatment of Moderate to Severe Plaque Psoriasis with Scalp, Nail and Palmoplantar Involvement Through 52 Weeks: Post-Hoc Analysis from the BE VIVID Phase 3 Trial. J of Skin [Internet]. 2021 Jan. 1 [cited 2024 Jul. 4];5(1):s18. Available from: https://jofskin.org/33014/index.php/skin/article/view/1171